Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD

Published:2006 Issue:4 Volume:73 Page:414-419
ISSN:0025-7931
Container-title:Respiration
language:en
Short-container-title:Respiration

Author:

Richter Kai,Stenglein Stephan,Mücke Marion,Sieder Christian,Schmidtmann Sören,Harnest Ulf,Weidinger Gottfried,Magnussen Helgo

Publisher

S. Karger AG

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update

2. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

3. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline

4. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil®AerolizerTM) with salbutamol (VentodiskTM)

5. Formoterol and Salmeterol in Partially Reversible Chronic Obstructive Pulmonary Disease: A Crossover, Placebo-Controlled Comparison of Onset and Duration of Action

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1.

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

;International Journal of Chronic Obstructive Pulmonary Disease;2020-11

2. Comparison of the rapid effects of single inhalations of formoterol and tiotropium bromide on respiratory function and COPD symptoms in a randomized crossover study;Respiratory Investigation;2017-11

3. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi;European Journal of Pharmacology;2015-08

4. Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD;European Journal of Radiology;2014-11

5. Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study;Respiratory Research;2014-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3